全文获取类型
收费全文 | 1437篇 |
免费 | 104篇 |
国内免费 | 18篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 53篇 |
妇产科学 | 78篇 |
基础医学 | 310篇 |
口腔科学 | 32篇 |
临床医学 | 148篇 |
内科学 | 338篇 |
皮肤病学 | 46篇 |
神经病学 | 80篇 |
特种医学 | 136篇 |
外科学 | 96篇 |
综合类 | 40篇 |
预防医学 | 50篇 |
眼科学 | 17篇 |
药学 | 77篇 |
中国医学 | 2篇 |
肿瘤学 | 49篇 |
出版年
2022年 | 7篇 |
2021年 | 24篇 |
2020年 | 17篇 |
2019年 | 23篇 |
2018年 | 26篇 |
2017年 | 18篇 |
2016年 | 29篇 |
2015年 | 37篇 |
2014年 | 43篇 |
2013年 | 64篇 |
2012年 | 45篇 |
2011年 | 36篇 |
2010年 | 60篇 |
2009年 | 51篇 |
2008年 | 44篇 |
2007年 | 48篇 |
2006年 | 47篇 |
2005年 | 33篇 |
2004年 | 46篇 |
2003年 | 46篇 |
2002年 | 33篇 |
2001年 | 16篇 |
2000年 | 37篇 |
1999年 | 29篇 |
1998年 | 54篇 |
1997年 | 54篇 |
1996年 | 52篇 |
1995年 | 36篇 |
1994年 | 44篇 |
1993年 | 38篇 |
1992年 | 38篇 |
1991年 | 32篇 |
1990年 | 22篇 |
1989年 | 43篇 |
1988年 | 41篇 |
1987年 | 25篇 |
1986年 | 23篇 |
1985年 | 19篇 |
1984年 | 11篇 |
1983年 | 18篇 |
1982年 | 18篇 |
1981年 | 16篇 |
1980年 | 16篇 |
1979年 | 7篇 |
1977年 | 21篇 |
1976年 | 12篇 |
1975年 | 8篇 |
1974年 | 6篇 |
1973年 | 5篇 |
1971年 | 6篇 |
排序方式: 共有1559条查询结果,搜索用时 15 毫秒
1.
2.
F. Palluault B. Soulez C. Slomianny E. Dei-Cas J. -Y. Cesbron D. Camus 《Parasitology research》1992,78(6):482-488
A method for embeddingPneumocystis carinii in hydrophilic resin (London Resin White) has been developed for immunocytochemistry studies. Using high osmotic pressure (about 850 mosmol) from fixation to embedding, this method improved the preservation of the fine structure as well as the antigenicity of rabbit-and SCID mouse-derivedP. carinii. Cytochemistry studies were performed using colloidal gold-conjugated lectins (concanavalin A, glycine max,Ulex europaeus) that reacted with the cytoplasmic components (endoplasmic reticulum, Golgi vesicles). Colloidal gold-conjugated streptavidin was also tested and was found to be reactive with the parasite cell wall and cytoplasmic components, which precludes its indiscriminate use inP. carinii immunocytochemistry studies.This investigation was supported in part by the Agence Nationale de Recherche sur le SIDA (ANRS). The senior author (F.P.) was awarded a scholarship from the Conseil Régional Nord-Pas de Calais 相似文献
3.
GP SCHWAB AL BLUM E BODNER B DALLEMAGNE K GLASER H KOOP F PACE W RÖSCH JR SIEWERT G WETSCHER 《Journal of gastroenterology and hepatology》1997,12(12):785-789
Gastroesophageal reflux disease (GERD) is the most common disease of the upper gastrointestinal tract. With the introduction of proton pump inhibitors medical treatment of GERD has been significantly improved. However, the development of laparoscopic antireflux surgery resulted in an increasing interest of surgeons in this disease. An interactive meeting was organized in order to develop an agreement between gastoenterologists and surgeons regarding therapeutic decisions and this is the main topic of this paper. 相似文献
4.
A. Wisanto P. Braeckmans M. Camus P. Devroey I. Khan C. Staesssen J. Smitz L. Van Waesberghe A. C. Van Steirteghem 《Journal of assisted reproduction and genetics》1988,5(2):107-111
Either a percutaneous-transvesical, a transvaginal, or a perurethral-transvesical approach can be used for oocyte recovery under ultrasound guidance in an in vitro fertilization and embryo transfer program. After having experienced these three different approaches in our program, we preferentially used the perurethral-transvesical approach as our routine technique for oocyte recovery under ultrasound guidance. We feel that this method is easier to perform and also carrier less risk for contamination. From January to December 1986, 186 oocyte retrievals under ultrasound guidance were performed. In 7 cases no oocytes were found despite normal ovarian stimulation. A total of 767 oocytes was collected; the fertilization rate was 71.8%. Forty pregnancies were achieved (21.5% per attempt or 27.7% per embryo replacement). Except for transient hematuria, no complications were observed. 相似文献
5.
P Pfitzenmeyer P Foucher F Piard B Coudert M L Braud P Gabez S Lacroix J P Mabille P Camus 《Thorax》1992,47(8):622-627
BACKGROUND: Nilutamide is a new, specific synthetic antiandrogen, released in several countries for the treatment of metastatic carcinoma of the prostate. Eight patients at the University Medical Centre at Dijon and affiliated referring hospitals developed reversible pulmonary opacities and respiratory symptoms while taking the drug. METHODS: Records of eight patients who developed new, otherwise unexplained chest opacities while taking nilutamide were reviewed. In each patient a careful aetiological search was made for other environmental or endogenous causes. Six patients underwent bronchoalveolar lavage, and lavage fluid was cultured. Corticosteroids were not given, unless gas exchange was compromised (two patients). RESULTS: The eight patients (all male) had had carcinoma of the prostate diagnosed on average 10.2 months earlier. All had improved with nilutamide, with a dramatic decrease of prostate specific antigen levels. Seven had received nilutamide at the recommended dosage of 150 mg/day, and one had received twice that amount. Treatment had lasted on average 113 (range 10-225) days, and the mean cumulated exposure was 21.8 (3-38) grams. The chest radiographs showed bilateral infiltrates, with no consistent topographic predilection. A restrictive lung defect was present in six patients and hypoxia in all (mean arterial oxygen tension (PaO2) 6.6 kPa). Bronchoalveolar lavage showed lymphocytosis in four patients and neutrophilia in two. The outcome was favourable in all patients after they had stopped nilutamide only (five patients), with corticosteroids (two patients) or a simple reduction of nilutamide from 300 to 150 mg/day (one patient). Recovery was associated with improvement of pulmonary function and PaO2. CONCLUSION: Nilutamide is associated with interstitial pneumonitis in about 1% of patients and appears reversible. 相似文献
6.
7.
8.
9.
10.
Albano C.; Smitz J.; Camus M.; Riethmuller-Winzen H.; Siebert-Weigel M.; Diedrich K.; Van Steirteghem A.C.; Devroey P. 《Human reproduction (Oxford, England)》1996,11(10):2114-2118
A third-generation gonadotrophin-releasing hormone antagonist(Cetrorelix) was used during ovarian stimulation in 32 patientsundergoing assisted reproduction, in order to prevent the prematureluteinizing hormone (LH) surge. In all patients, ovarian stimulationwas carried out with two or three ampoules of human menopausalgonadotrophin (HMG), starting on day 2 of the menstrual cycle.In addition, 0.5 mg of Cetrorelix was administered daily fromday 6 of HMG treatment until the day of ovulation inductionby human chorionic gonadotrophin (HCG). A significant drop inplasma LH concentration was observed within a few hours of thefirst administration of Cetrorelix (P<0.005). Moreover, noLH surge was detected at any point in the treatment period inany of the 32 patients. A mean oestradiol concentration of 2122±935ng/1 was observed on the day of the HCG administration, indicatingnormal folliculogenesis. Like LH, progesterone concentrationalso dropped within a few hours of the first administrationof Cetrorelix (P< 0.005). A 0.5 mg daily dose of Cetrorelixprevented a premature LH surge in all the 32 patients treated. 相似文献